Validation of an LC–MS/MS method for the determination of sotorasib, a KRASG12C inhibitor, in human plasma

This study was sponsored by Amgen, Inc. All authors are employees of Amgen, Inc., and own stock in Amgen, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

留言 (0)

沒有登入
gif